Briefly, these results indicated that treatment with ADT-OH in combination with VNP-FADD significantly increased the protein level of FADD in tumour tissues and then induced apoptosis, thereby inhibiting tumour growth and improving the survival rate of tumour-bearing mice. The gene discussed is FADD; the disease is neoplasm.